Years ago, no math education was complete without understanding how to compute a square root. Today, you are probably just reaching for a calculator, or if you are writing a program, you’ll probably ...

Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA nephropathy, along with key clinical advancements in its kidney disease ...

Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep ...

[SINGAPORE] Indonesia-based employment platform Pintarnya has raised a US$16.7 million Series A round. The round was led by venture capital firm Square Peg, with existing investor Vertex Ventures ...

The Roots are coming to Portland’s Pioneer Courthouse Square as part of the summer concert series on Thursday, August 21 at 7 p.m. Tickets are still currently available starting at a few different ...

The recent Vertex Pharmaceuticals Incorporated stock drop after VX-993 trial results is overblown; the pain franchise remains robust with multiple promising avenues and ongoing trials. Vertex's CF ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...

Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex Pharmaceuticals said Monday that ...

CHICAGO (WLS) -- Square Roots returns July 11 through July 13, drawing more than 40,000 attendees to the heart of Lincoln Square to celebrate music, craft beer, local food, and community spirit. The ...

A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin, according to new data from a phase 1/2 trial. One-year ...